VGNKI has developed a new drug for the treatment of salmonellosis in piglets

An experimental drug based on bacteriophages for the treatment and prevention of salmonellosis in piglets has been developed at the Center for Quality and Standardization of Medicines for Animals and Feed (VGNKI), subordinated to ROSSELKHOZNADZOR.

About a new medicine that can become a worthy alternative to antibiotics in pig breeding, at the summit “Agrarian Policy of Russia: Safety and Quality of Products” as part of the exhibition “Meat Industry. Chicken King. Refrigeration industry for the agro-industrial complex & VIV ”said Olga Ivanova, HEAD of the VGNKI biotechnology department.

According to her, the laboratory staff received an experimental drug and approved a method for controlling its quality. Now they are working on a new drug regimen. 

Recently, VGNKI scientists began to form a collection of antibiotic-resistant strains of microorganisms. RUSSIA has approved a strategy to prevent the spread of antimicrobial resistance, so now it is important to establish how quickly it develops in a particular case, and what scheme will be used to prevent diseases caused by such pathogens, and how they can be treated.

Another direction of the center's work was the classification of antimicrobial drugs recommended for use in veterinary medicine, drugs that are better not to use and prohibited in the treatment of animals.

Illicit drugs are assigned to category A. Category B includes drugs used in veterinary medicine and medicine: they can be used in cases where the “first choice” drugs (group C) have not worked. Group D combines products used in a certain period of animal rearing. Everything that belongs to groups B and C can be purchased exclusively by prescription.

According to Olga Ivanova, the main activities of the Department of Biotechnology of VGNKI are veterinary monitoring and the development of PCR methods for screening detection of pathogen resistance genes to virtually all groups of antimicrobial drugs.